These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 23659288)
1. The use of levosimendan in children with cancer with severe acute cardiac dysfunction: case series and a review of the literature. Tosoni A; Dipchand AI; Mohseni-Bod H Cardiol Young; 2014 Jun; 24(3):524-7. PubMed ID: 23659288 [TBL] [Abstract][Full Text] [Related]
2. [Acute hemodynamic and clinical effects of a new inotropic agent, levosimendan, in patients with severe heart failure]. Porcu M; Orrù P Ital Heart J Suppl; 2001 Feb; 2(2):205-6. PubMed ID: 11255888 [No Abstract] [Full Text] [Related]
3. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children]. Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317 [TBL] [Abstract][Full Text] [Related]
4. Levosimendan: a new option in acute septic cardiac failure? Powell BP; De Keulenaer B Emerg Med Australas; 2007 Apr; 19(2):177; author reply 177-8. PubMed ID: 17448109 [No Abstract] [Full Text] [Related]
5. Levosimendan: a retrospective single-center case series. Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721 [TBL] [Abstract][Full Text] [Related]
6. European experience on the practical use of levosimendan in patients with acute heart failure syndromes. Follath F; Franco F; Cardoso JS Am J Cardiol; 2005 Sep; 96(6A):80G-5G. PubMed ID: 16181827 [TBL] [Abstract][Full Text] [Related]
7. Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials. Delaney A; Bradford C; McCaffrey J; Bagshaw SM; Lee R Int J Cardiol; 2010 Feb; 138(3):281-9. PubMed ID: 18817994 [TBL] [Abstract][Full Text] [Related]
8. [Use of levosimendan in acute heart failure and its effect on renal function]. Moyano AP; Hidalgo RL; Grande DB; Morales SC Nefrologia; 2009; 29(6):616-7. PubMed ID: 19936016 [No Abstract] [Full Text] [Related]
9. Early experience with Levosimendan in children with ventricular dysfunction. Namachivayam P; Crossland DS; Butt WW; Shekerdemian LS Pediatr Crit Care Med; 2006 Sep; 7(5):445-8. PubMed ID: 16885788 [TBL] [Abstract][Full Text] [Related]
10. Levosimendan: a new approach for the treatment of patients with severe heart failure. A brief summary based on a clinical case. Morais J; Dias B; Pontes N Rev Port Cardiol; 2003; 22(7-8):941-8. PubMed ID: 14587161 [TBL] [Abstract][Full Text] [Related]
11. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure. Earl GL; Fitzpatrick JT Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899 [TBL] [Abstract][Full Text] [Related]
12. Levosimendan: a new option in acute cardiac failure. Holley AD; Ziegenfuss M Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641 [No Abstract] [Full Text] [Related]
13. Oral levosimendan in patients with severe chronic heart failure --the PERSIST study. Nieminen MS; Cleland JG; Eha J; Belenkov Y; Kivikko M; Põder P; Sarapohja T Eur J Heart Fail; 2008 Dec; 10(12):1246-54. PubMed ID: 18945637 [TBL] [Abstract][Full Text] [Related]
14. Drug discovery and development for acute heart failure drugs: are expectations too high? Pollesello P Int J Cardiol; 2014 Mar; 172(1):11-3. PubMed ID: 24472177 [No Abstract] [Full Text] [Related]